296 related articles for article (PubMed ID: 32289279)
61. Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.
ElMallah MK; Falk DJ; Lane MA; Conlon TJ; Lee KZ; Shafi NI; Reier PJ; Byrne BJ; Fuller DD
Hum Gene Ther Methods; 2012 Apr; 23(2):148-56. PubMed ID: 22693957
[TBL] [Abstract][Full Text] [Related]
62. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
Saraiva J; Nobre RJ; Pereira de Almeida L
J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
[TBL] [Abstract][Full Text] [Related]
63. Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.
Rashnonejad A; Amini Chermahini G; Gündüz C; Onay H; Aykut A; Durmaz B; Baka M; Su Q; Gao G; Özkınay F
Mol Ther; 2019 Dec; 27(12):2123-2133. PubMed ID: 31543414
[TBL] [Abstract][Full Text] [Related]
64. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.
Chai Z; Zhang X; Rigsbee KM; Wang M; Samulski RJ; Li C
J Control Release; 2018 Sep; 286():415-424. PubMed ID: 30107215
[TBL] [Abstract][Full Text] [Related]
65. Sensorimotor Cortex Injection of Adeno-Associated Viral Vector Mediates Knockout of PTEN in Neurons of the Brain and Spinal Cord of Mice.
Yang P; Qin Y; Zhang W; Bian Z; Wang R
J Mol Neurosci; 2015 Dec; 57(4):470-6. PubMed ID: 26160695
[TBL] [Abstract][Full Text] [Related]
66. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
[TBL] [Abstract][Full Text] [Related]
67. Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis.
Werner MS; Aras S; Morgan AR; Roamer J; Param NJ; Olagbegi K; Lamontagne RJ; Greig JA; Wilson JM
Cancer Gene Ther; 2024 May; 31(5):766-777. PubMed ID: 38480976
[TBL] [Abstract][Full Text] [Related]
68. Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle.
Zheng H; Qiao C; Wang CH; Li J; Li J; Yuan Z; Zhang C; Xiao X
Hum Gene Ther; 2010 Jan; 21(1):87-97. PubMed ID: 19719401
[TBL] [Abstract][Full Text] [Related]
69. Slow Infusion of Recombinant Adeno-Associated Viruses into the Mouse Cerebrospinal Fluid Space.
Wang D; Li J; Tran K; Burt DR; Zhong L; Gao G
Hum Gene Ther Methods; 2018 Apr; 29(2):75-85. PubMed ID: 29596011
[TBL] [Abstract][Full Text] [Related]
70. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
[TBL] [Abstract][Full Text] [Related]
71. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
72. Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders.
Marchi PM; Marrone L; Azzouz M
Trends Mol Med; 2022 Jan; 28(1):79-80. PubMed ID: 34756547
[No Abstract] [Full Text] [Related]
73. Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?
Bey K; Deniaud J; Dubreil L; Joussemet B; Cristini J; Ciron C; Hordeaux J; Le Boulc'h M; Marche K; Maquigneau M; Guilbaud M; Moreau R; Larcher T; Deschamps JY; Fusellier M; Blouin V; Sevin C; Cartier N; Adjali O; Aubourg P; Moullier P; Colle MA
Mol Ther Methods Clin Dev; 2020 Jun; 17():771-784. PubMed ID: 32355866
[TBL] [Abstract][Full Text] [Related]
74. Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates.
Samaranch L; Bringas J; Pivirotto P; Sebastian WS; Forsayeth J; Bankiewicz K
Hum Gene Ther Methods; 2016 Feb; 27(1):13-6. PubMed ID: 26757202
[TBL] [Abstract][Full Text] [Related]
75. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
[TBL] [Abstract][Full Text] [Related]
76. Transparenchymal Renal Pelvis Injection of Recombinant Adeno-Associated Virus Serotype 9 Vectors Is a Practical Approach for Gene Delivery in the Kidney.
Shen X; Xu Y; Bai Z; Ma D; Niu Q; Meng J; Fan S; Zhang L; Hao Z; Zhang X; Liang C
Hum Gene Ther Methods; 2018 Dec; 29(6):251-258. PubMed ID: 30458119
[TBL] [Abstract][Full Text] [Related]
77. Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci.
Shen F; Kuo R; Milon-Camus M; Han Z; Jiang L; Young WL; Su H
Stroke; 2013 Jan; 44(1):252-4. PubMed ID: 23250995
[TBL] [Abstract][Full Text] [Related]
78. AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.
Hardcastle N; Boulis NM; Federici T
Expert Opin Biol Ther; 2018 Mar; 18(3):293-307. PubMed ID: 29249183
[TBL] [Abstract][Full Text] [Related]
79. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
80. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport.
Lu YY; Wang LJ; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
Neurosci Res; 2003 Jan; 45(1):33-40. PubMed ID: 12507722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
